ℹ️
🇬🇧
Search
Search for publications relevant for "ibandronate"
ibandronate
Publication
Class
Person
Publication
Programmes
publication
Advantage of intravenous ibandronate.
2008 |
First Faculty of Medicine
publication
Influence of incidence of hip fractures by therapy of ibandronate
2008 |
First Faculty of Medicine
publication
Intravenous ibandronate injection: clinical experience
Publication without faculty affiliation
publication
Oral Ibandronate Therapy in Three Patients with Osteogenesis Imperfecta
2021 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Preparation and properties of new co-crystals of ibandronate with gluco- or galactopyranoside derivatives
2010 |
Central Library of Charles University
publication
Ibandronate - efficacy that does not decline over time
2011 |
First Faculty of Medicine
publication
Ibandronic acid
2006 |
First Faculty of Medicine
publication
Intravenous ibandronate injections are at least as effective as daily oral ibandronate: consistent effect across subgroups
Publication without faculty affiliation
publication
Sekvenční léčba osteoporózy: účinky ibandronátu po ukončení léčby teriparatidem
Publication without faculty affiliation
publication
The efficacy of monthly oral ibandronate (150 mg) is maintained: MOBILE Study long-term extension
Publication without faculty affiliation
publication
Monthy oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis: 1-year results from mobile
Publication without faculty affiliation
publication
Progressive efficacy improvements with quarterly intravenous ibandronate injections: the DIVA study long term extension
Publication without faculty affiliation
publication
Favorable renal tolerability with intermittent intravenous ibandronate injections: the DIVA study
Publication without faculty affiliation
publication
Intermittent intravenous ibandronate injections: a new therapeutic option for preventing postmenopausal bone loss
Publication without faculty affiliation
publication
Once-monthly and daily oral ibandronate are similarly well tolerated in women with postmenopausal osteoporosis: 2-year results from MOBILE
Publication without faculty affiliation
publication
The influence of vitamin D deficiency and hormonal status on response of bone to ibandronate in patients with klinefelter's syndrome
Publication without faculty affiliation
publication
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women
2003 |
First Faculty of Medicine
publication
Once-monthly dosing of oral ibandronate is at least as effective as daily dosing in postmenoupausal osteoporosis: 1-year results from mobile
Publication without faculty affiliation
publication
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
2006 |
First Faculty of Medicine
publication
Pronounced increases in bone mineral density with intermittent intravenous ibandronate injections: 2-year results from DIVA
Publication without faculty affiliation
publication
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women
2003 |
Faculty of Physical Education and Sport
publication
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
2006 |
Faculty of Physical Education and Sport
publication
Consistent efficacy with intermittent intermittent intravenous ibandronate injections in postmenopausal osteoporosis: DIVA 2-year analysis
Publication without faculty affiliation
publication
Guidelines for diagnostics and therapy of postmemnopausal osteoporosis. Second part
2007 |
Publication without faculty affiliation
publication
Guidelines for diagnostics and therapy of postmemnopausal osteoporosis. Second part
2007 |
Central Library of Charles University, Faculty of Medicine in Hradec Králové
publication
Guidelines for diagnostics and therapy of postmemnopausal osteoporosis. Second part
2007 |
First Faculty of Medicine
publication
Intravenous ibandronate in osteoporotic men with Klinefelter´s syndrome: Effects on bone mineral density and biochemical markers during 3-2-years treatment and after withdrawal
Publication without faculty affiliation
publication
The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status
2003 |
First Faculty of Medicine
publication
The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status
2003 |
Faculty of Physical Education and Sport
publication
Serum activity of type 5B ACP and biochemical markers of type 1 collagen degradation in osteoporotic men with Klinefelter's syndrome treated with an intravenous ibandronate
Publication without faculty affiliation